考虑异质癌细胞的模型的一般性评估，用于预测针对非小细胞肺癌的立体定向放射治疗的肿瘤控制概率。
Generality Assessment of a Model Considering Heterogeneous Cancer Cells for Predicting Tumor Control Probability for Stereotactic Body Radiation Therapy Against Non-Small Cell Lung Cancer.
发表日期：2024 Apr
作者：
Ryo Saga, Yusuke Matsuya, Hideki Obara, Fumio Komai, Hironori Yoshino, Masahiko Aoki, Yoichiro Hosokawa
来源：
Stem Cell Research & Therapy
摘要：
通过将模型与非立体定向身体放射治疗的公开数据进行比较，提出了考虑癌症干细胞样细胞的体外克隆生存预测肿瘤控制概率的模型（所谓的集成微剂量动力学模型）的一般性。小细胞肺癌细胞。© 2024 作者。
The generality of a model for predicting tumor control probability from in vitro clonogenic survival considering of cancer stem-like cells, the so-called integrated microdosimetric-kinetic model, is presented by comparing the model to public data on stereotactic body radiation therapy for non-small cell lung cancer cells.© 2024 The Authors.